Katherine Stueland, Chief Executive Officer at GeneDx Holdings Corp. (WGS), sold 93,102 shares at $95.66 ($8.9M) on 2025-03-26, disclosed to the SEC on 2025-03-28.
Open-market sale of $8.9M WGS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.59 | 1,750 | $166K | 1.9% |
| 2 | $94.59 | 1,750 | $166K | 1.9% |
| 3 | $95.66 | 44,801 | $4.3M | 48.1% |
| 4 | $95.66 | 44,801 | $4.3M | 48.1% |
| Total | $95.62 avg | 93,102 | $8.9M | 100% |
| Filing → |
| WGS | SELL | 2026-06-18 | $638K | — | Filing → |
| WGS | SELL | 2026-06-11 | $196K | — | Filing → |
| WGS | SELL | 2026-05-01 | $142K | — | Filing → |